Cardiologist with 20 years of experience shares the truth behind GLP-1 drugs and weight loss: ‘Disaster always follows…’
Dr Bhojraj explains that GLP-1 isn’t a medication but a natural hormone, and while it can help, they have side effects and aren’t meant for lifelong use.
Bariatric surgery reshapes body fat and muscle more than GLP-1 drugs
Bariatric surgery and GLP-1 treatments reshape body composition differently, emphasizing the importance of sex and treatment choice in muscle preservation.
The Hindu Lit for Life 2026 | Some of India’s foremost experts on what the future could hold in the health ecosystem
The rise and riseof GLP-1 medications, why lived experiences are important in the context of mental health and why the new US dietary guidelines should be taken with a pinch of salt — panellists at The Hindu Lit for Life’s 2026 edition unpack some important health trends
Gordon Ramsay Ushers I Can’t Believe It’s Not Butter Into the GLP-1 Era
Brand hopes chef can boost appeal among nutrient-conscious foodies.
Shed Expands GLP-1 Weight-Loss Offerings with Wegovy® Pills via NovoCare
SALT LAKE CITY, Jan. 14, 2026 /PRNewswire/ — Shed, a leading health and wellness platform focused on accessible, clinician-guided care, today announced the expansion of its GLP-1 weight-loss programs with the introduction of Wegovy® pills via NovoCare. This new offering provides members…
This Director Sold 42,000 Shares of Wave Life Sciences for $630,000. What Investors Should Know About This Biotech Company.
Key Points Adrian Rawcliffe disposed of 42,000 shares for a total transaction value of ~$630,000 on Dec. 8, 2025. This transaction was derivative-based, involving the exercise and immediate sale of options; all activity was through direct ownership with no indirect entities involved. These 10 stocks could mint the next wave of millionaires › On Dec. […]
Is It Time to Dump Your Shares of Eli Lilly?
Key Points Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has now introduced a pill version of its GLP-1 weight loss drug. Eli Lilly’s valuation looks stretched at this point — both against the industry and overall market. 10 stocks we like better than […]
Is It Time to Dump Your Shares of Eli Lilly?
If you bought Eli Lilly (NYSE: LLY) shares five years ago, you are sitting on some massive gains. The stock is up over 470% compared to a gain of roughly 85% for the S&P 500 index and a roughly 4% advance for the average pharmaceutical stock. Should you hold on to a big winner like […]
Stopping GLP-1s May Lead to Weight Regain In Less Than 2 Years, Review Finds
Research shows that people who stop taking GLP-1 medications regain weight within 2 years. Image Credit: Tatsiana Volkava/Getty Images A new study has found that people regain weight within 2 years of stopping a GLP-1 drug. Metabolic improvements also tend to fade within that time, researchers found. Experts advise that slowly tapering off the medication […]
STAT+: Pharmalittle: We’re reading about a change in obesity drug warnings, FDA approvals, and more
Good morning, everyone, the middle of the week has arrived and this calls for a celebratory cup or two of stimulation. How so? Well, you made it this far, which can be an accomplishment, after all. Moreover, there is always good reason to forge ahead, given that there is so much more to do and […]